Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Viridian Therapeutics, Inc.\DE (VRDN) Debt Ratio (2016 - 2025)

Viridian Therapeutics, Inc.\DE has reported Debt Ratio over the past 9 years, most recently at 0.04 for Q4 2025.

  • Quarterly results put Debt Ratio at 0.04 for Q4 2025, changed N/A from a year ago — trailing twelve months through Dec 2025 was 0.04 (changed N/A YoY), and the annual figure for FY2025 was 0.04, changed.
  • Debt Ratio for Q4 2025 was 0.04 at Viridian Therapeutics, Inc.\DE, up from 0.04 in the prior quarter.
  • Over the last five years, Debt Ratio for VRDN hit a ceiling of 0.04 in Q4 2023 and a floor of 0.03 in Q3 2024.
  • Median Debt Ratio over the past 3 years was 0.04 (2025), compared with a mean of 0.03.
  • Peak annual rise in Debt Ratio hit 36.14% in 2025, while the deepest fall reached 2.23% in 2025.
  • Viridian Therapeutics, Inc.\DE's Debt Ratio stood at 0.04 in 2023, then tumbled by 35.47% to 0.03 in 2024, then surged by 43.2% to 0.04 in 2025.
  • The last three reported values for Debt Ratio were 0.04 (Q4 2025), 0.04 (Q3 2025), and 0.04 (Q2 2025) per Business Quant data.